(Press-News.org) Drug approval requires a deep understanding of the mechanism of action
The team of Julia Bandow, who heads the RUB's Junior Research Group Microbial Antibiotic Research, has been studying the MP196 peptide as a representative of a group of very small positively charged peptides that consist of some four to ten amino acids. Earlier studies had shown that MP196 is efficient against various bacteria, including particularly problematic multi-resistant pathogens that frequently cause sepsis. How MP196 kills bacteria remained unclear. However, in order for a new substance to be approved as a drug, its mechanism of action has to be fully understood.
Peptide disrupts cell wall biosynthesis and cell respiration
The biologists have closed this gap. They showed that the MP196 peptide integrates into the bacterial cell membrane. In doing so, it delocalises proteins localised at the bacterial cell membrane that participate in vital processes. Two processes in particular are severely affected: MP196 disrupts the biosynthesis of the cell wall, i.e. of the outer envelope that encloses the cell membrane and provides physical stability. It also inhibits cell respiration and, consequently, the production of the energy-storing molecule ATP. This results in cellular energy deficiency, thus preventing the synthesis of macromolecules vital for bacterial growth.
Developing resistances against MP196 may be particularly difficult
"By delocalising crucial membrane proteins, MP196 disrupts a number of cellular processes that take place at the membrane," says Julia Bandow. "As a result, the development of resistance against the peptide seems particularly difficult." The researchers are confident that MP196 can serve as a scaffold to develop drugs that attack certain classes of bacteria without damaging human cells. The interaction of MP196 with the cell membrane was dependent on the fatty acids present in the membrane. The membrane composition varies not only between human and bacterial cells, but also between different classes of bacteria.
INFORMATION:
The project "Innovative Antibiotics from NRW"
This study was part of the project "Innovative Antibiotics from NRW" (InA) that was co-financed by the State of North Rhine-Westphalia and the European Union's European Regional Development Fund "Investing in your Future" within the framework of the "BIO.NRW.red" cluster. Together with partners from academia and industry, the RUB microbiologists and chemists also study the antibiotic potential of organometallic compounds.
Bibliographic record
M. Wenzel et al. (2014): Small cationic antimicrobial peptides delocalize peripheral membrane proteins, Proceedings of the National Academy of Sciences, DOI: 10.1073/pnas.1319900111
Further information
Prof Dr Julia Bandow, Junior Research Group Microbial Antibiotic Research, Faculty of Biology and Biotechnology at the Ruhr-Universität, 44780 Bochum, Germany, phone +49/234/32-23102, email: julia.bandow@rub.de
One click away
Full-length article on the RUB's research into antibiotics with pictures
http://rubin.rub.de/en/international-edition-2014/bacteria-under-fire
Editor: Dr Julia Weiler
Small peptides as potential antibiotics
Research team decodes the effects of an antimicrobial peptide on bacterial cells
2014-03-25
ELSE PRESS RELEASES FROM THIS DATE:
VTT: Building to take note of individual human thermal comfort
2014-03-25
Because people in developed countries spend about 90% of their time indoors, their sense of warmth becomes one key comfort factor for interior spaces. VTT Technical Research Centre of Finland has developed a new method for assessing the individual thermal comfort experienced by different user groups. The design of energy efficient buildings – such as day care centres, schools, offices and homes for the elderly – should pay more attention in future to the thermal comfort of user groups according to real needs.
The new method developed for assessing thermal comfort (Human ...
Simple, like a neutron star
2014-03-25
In how many ways can one describe an object? Take an apple: by just looking at it we can easily estimate its weight, shape and colour but we are unable to describe it at any other level, for example, to evaluate the chemical composition of its flesh. Something similar also applies to astronomical objects: until today one of the challenges facing scientists was to describe neutron stars at the nuclear physics level. The matter these stars are made up of is in fact extremely complex, and several complicated equations of state have been proposed. However, to date there is ...
New technique brings us closer to HIV and Hepatitis C vaccines
2014-03-25
Plans for a new type of DNA vaccine to protect against the deadly HIV and Hepatitis C viruses have taken an important step forward, with University of Adelaide researchers applying for a patent based on groundbreaking new research.
Professor Eric Gowans from the University's Discipline of Surgery, based at the Basil Hetzel Institute at the Queen Elizabeth Hospital, has submitted a patent application for what he describes as a relatively simple but effective technique to stimulate the body's immune system response, thereby helping to deliver the vaccine.
While pre-clinical ...
Catheter innovation destroys dangerous biofilms
2014-03-25
DURHAM, N.C. -- For the millions of people forced to rely on a plastic tube to eliminate their urine, developing an infection is nearly a 100 percent guarantee after just four weeks. But with the help of a little bubble-blowing, biomedical engineers hope to bring relief to urethras everywhere.
About half of the time, the interior of long-term urinary catheters become plagued by biofilms -- structures formed by colonies of bacteria that are extremely difficult to kill. Once established, it is only a matter of time before the biofilm becomes a welcoming host for other, ...
Doxorubicin alone or with ifosfamide for treating soft tissue sarcoma?
2014-03-25
An EORTC study published in The Lancet Oncology does not support administration of intensified doxorubicin and ifosfamide for palliation of advanced soft tissue sarcoma, unless the objective is to shrink the tumor.
Dr. Ian Judson of the Royal Marsden Hospital in London and coordinator of this study says, "Our clinical trial was designed to compare combination treatment with doxorubicin and ifosfamide to treatment with doxorubicin alone, and our results show that the combination chemotherapy did not improve overall survival. So, if the goal of treatment is to control the ...
Leading surgeons warn against media hype about tracheal regeneration
2014-03-25
Beverly, MA, March 24, 2014 – Reports of the two earliest tissue-engineered whole organ transplants using a windpipe, or trachea, created using the patient's own stem cells, were hailed as a breakthrough for regenerative medicine and widely publicized in the press. However, two leading transplant surgeons in Belgium warn of the dangers of media attention, and urge that tracheal bioengineering be demonstrated as both effective and safe before further transplants take place. Their views are published in an Editorial in The Journal of Thoracic and Cardiovascular Surgery, an ...
Research study takes deeper look at the role of gut microbes in the immune system
2014-03-25
LOS ANGELES (March 24, 2014) – New research suggests that gut microorganisms do not merely influence immune cell function, but also support the production of immune cells that form the first line of defense against infection. By understanding the mechanisms responsible for maintaining and replacing immune cells, researchers hope to one day develop targeted therapies to support and boost immune function in humans.
Study investigators from the Regenerative Medicine Institute at Cedars-Sinai collaborated with the Mount Sinai School of Medicine and lead institution — the ...
Replacing insulin through stem cell-derived pancreatic cells under the skin
2014-03-25
LA JOLLA, Calif., March 25, 2014 – Sanford-Burnham Medical Research Institute (Sanford-Burnham) and UC San Diego School of Medicine scientists have shown that by encapsulating immature pancreatic cells derived from human embryonic stem cells (hESC), and implanting them under the skin in animal models of diabetes, sufficient insulin is produced to maintain glucose levels without unwanted potential trade-offs of the technology. The research suggests that encapsulated hESC-derived insulin-producing cells hold great promise as an effective and safe cell-replacement therapy ...
Complex brain functional network connection after stroke
2014-03-25
Studies have shown that functional network connection models can be used to study brain network changes in patients with schizophrenia. A research team from Huazhong University of Science and Technology in China inferred that these models could also be used to explore functional network connectivity changes in stroke patients. The researchers used independent component analysis to find the motor areas of stroke patients, which is a novel way to determine these areas. Functional magnetic resonance imaging datasets were collected from healthy controls and right-handed stroke ...
Technofossils -- an unprecedented legacy left behind by humans
2014-03-25
A new study by an international team of scientists, including Dr Jan Zalasiewicz and Professor Mark Williams of the University of Leicester's Department of Geology, suggests that the fossil impact humans have made on the planet is vast and unprecedented in nature – and that there's been nothing remotely like it since the Earth formed, over four and half billion years ago.
The study, entitled 'The technofossil record of humans' and published by SAGE in The Anthropocene Review, argues that, like dinosaurs, who left their bones and footprints behind for future generations ...
LAST 30 PRESS RELEASES:
From blood sugar to brain relief: GLP-1 therapy slashes migraine frequency
Variability in heart rate during sleep may reveal early signs of stroke, depression or cognitive dysfunction, new study shows
New method to study catalysts could lead to better batteries
Current Molecular Pharmacology impact factor rises to 2.9, achieving Q2 ranking in the Pharmacology & Pharmacy category in 2024 JCR
More time with loved ones for cancer patients spared radiation treatment
New methods speed diagnosis of rare genetic disease
Genetics of cardiomyopathy risk in cancer survivors differ by age of onset
Autism inpatient collection releases genetic, phenotypic data for more than 1,500 children with autism
Targeting fusion protein’s role in childhood leukemia produces striking results
Clear understanding of social connections propels strivers up the social ladder
New research reveals why acute and chronic pain are so different – and what might make pain last
Stable cooling fostered life, rapid warming brought death: scientists use high-resolution fusuline data reveal evolutionary responses to cooling and warming
New research casts doubt on ancient drying of northern Africa’s climate
Study identifies umbilical cord blood biomarkers of early onset sepsis in preterm newborns
AI development: seeking consistency in logical structures
Want better sleep for your tween? Start with their screens
Cancer burden in neighborhoods with greater racial diversity and environmental burden
Alzheimer disease in breast cancer survivors
New method revolutionizes beta-blocker production process
Mechanism behind life-threatening cancer drug side-effect revealed
Weighted vests might help older adults meet weight loss goals, but solution for corresponding bone loss still elusive
Scientists find new way to predict how bowel cancer drugs will stop working – paving the way for smarter treatments
Breast cancer patients’ microbiome may hold key to avoiding damaging heart side-effects of cancer therapies
Exercise-induced protein revives aging muscles and bones
American College of Cardiology issues guidance on weight management drugs
Understanding the effect of bedding on thermal insulation during sleep
Cosmic signal from the very early universe will help astronomers detect the first stars
With AI, researchers find increasing immune evasion in H5N1
Study finds hidden effects of wildfires on water systems
Airborne fungal spores may help predict COVID-19 & flu surges
[Press-News.org] Small peptides as potential antibioticsResearch team decodes the effects of an antimicrobial peptide on bacterial cells